Mar 26, 2024 4:10pm EDT Stevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters’ Option to Purchase Additional Ordinary Shares
Mar 21, 2024 11:45pm EDT Stevanato Group Announces Pricing of Upsized Public Offering of Ordinary Shares
Mar 11, 2024 5:05pm EDT Stevanato Group to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum
Feb 22, 2024 4:30pm EST Stevanato Group to Report Fourth Quarter and Year End 2023 Financial Results on March 7, 2024
Jan 24, 2024 8:00am EST Stevanato Group Launches EZ-fill® Kit and Laboratory Fill and Finish Service to Support Small Batch Drug Development and Commercialization
Jan 03, 2024 4:30pm EST Stevanato Group to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Nov 16, 2023 6:00am EST Stevanato Group's Mavis™ Combi Visual Inspection Machine Selected as Pharma Innovation Award Winner by Pharma Manufacturing